CAL
RNAM

Capital Analysts LLC’s Avidity Biosciences RNAM Stock Holding History

Capital Analysts LLC’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-143
Closed -$10K – 1581
2025
Q4 		$10K Hold
143
– – ﹤0.01% 1250
2025
Q3 		$6K Hold
143
– – ﹤0.01% 1282
2025
Q2 		$4K Hold
143
– – ﹤0.01% 1278
2025
Q1 		$4K Buy
+143
New +$4.45K ﹤0.01% 1265

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Capital Analysts LLC's RNAM Position: Q1 2026 in Review

Capital Analysts LLC sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 143 shares — an estimated $10K sold.

Capital Analysts LLC first reported a position in RNAM in Q1 2025 and held it in 4 quarters. The position peaked at $10K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Capital Analysts LLC reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Capital Analysts LLC sold 143 Avidity Biosciences shares in Q1 2026, an estimated $10K.
  • Capital Analysts LLC first reported a position in Avidity Biosciences in Q1 2025 and held it in 4 quarters.
  • Capital Analysts LLC's Avidity Biosciences position peaked at $10K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.